Nkarta, Inc. Commercial Paper, at Carrying Value
Nkarta, Inc. (NKTX) had Commercial Paper, at Carrying Value of $4.99 million as of 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Notes › Cash Equivalents, at Carrying Value
us-gaap:CommercialPaperAtCarryingValue · last filed 2022-08-11
- 2022-06-30: Commercial Paper, at Carrying Value $4.99M.
- 2019-12-31: Commercial Paper, at Carrying Value $2.40M; Commercial Paper, at Carrying Value as first filed $2.40M.
| Period end | Commercial Paper, at Carrying Value | Commercial Paper, at Carrying Value as first filed |
|---|---|---|
| 2022-06-30 | $4.99M 10-Q · filed 2022-08-11 | |
| 2019-12-31 | $2.40M 10-K · filed 2021-03-25 | $2.40M 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |